NextCure, Inc. SEC filings NXTC
NextCure, Inc. has 394 filings in SEC EDGAR's recent list, going back to Jan 11, 2016. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 30, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Sep 25, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Change in control, Officer or director change, Regulation FD disclosure, Other events
|
Jul 14, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 25, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 23, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 17, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 14, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 10, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jun 16, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2025 | Apr 10, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 3, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2023 | Jul 15, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 26, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 3, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2021 | Nov 13, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 4, 2021 | Oct 1, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2021 | Sep 21, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Other events
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2021 | Mar 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2021 | Feb 21, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2021 | Jan 14, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 14, 2020 | Sep 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2020 | Jul 27, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2020 | Jul 14, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 13, 2020 | Jul 8, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2020 | Apr 13, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 30, 2020 | Mar 25, 2020 |
| 8-K |
Current report
Agreement ended
|
Jan 13, 2020 | Jan 10, 2020 |
| 8-K |
Current report
Other events
|
Dec 2, 2019 | Dec 2, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2019 | Oct 2, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 9, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
May 13, 2019 | May 13, 2019 |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NXTC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Baltimore, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1661059
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.